Page last updated: 2024-08-21

cepharanthine and Lymphoma, Primary Effusion

cepharanthine has been researched along with Lymphoma, Primary Effusion in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hiyoshi, M; Katano, H; Ohsugi, T; Okada, S; Suzu, S; Takahashi-Makise, N; Umezawa, K1

Other Studies

1 other study(ies) available for cepharanthine and Lymphoma, Primary Effusion

ArticleYear
Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
    International journal of cancer, 2009, Sep-15, Volume: 125, Issue:6

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Blotting, Western; Caspase Inhibitors; Caspases; Cell Cycle; Cell Proliferation; Electrophoretic Mobility Shift Assay; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunoenzyme Techniques; In Vitro Techniques; Lymphoma, Primary Effusion; Male; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Polymerase Chain Reaction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2009